Clinical Trial Update: Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face [Phase 2]

View source ↗

Summary

Phase 2 trial of topical tazarotene for basal cell skin cancer and basal cell nevus syndrome on the face has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma
• Basal Cell Nevus Syndrome

Drugs mentioned

• TAZAROTENE (TAZAROTENE)

Snippet

Sponsor: UCSF Benioff Children's Hospital Oakland | Conditions: Neoplastic Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2016-02-11